MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    GLP1R Expression and Parkinson’s Disease and Related Disorders in GLP-1RA–Treated Type 2 Diabetes

    KA. Woo, Y. Jang, P. Park, HJ. Kim (Seoul, Republic of Korea)

    Objective: We tested whether interindividual differences in systemic GLP1R expression are associated with PDRD risk among adults with type 2 diabetes initiating GLP-1RAs. Background: Preclinical…
  • 2026 International Congress

    Pregnancy and Breastfeeding in Early-Onset Parkinson’s Disease:Therapeutic Challenges of Levodopa Monotherapy.A case Report.

    K. Salinas-Barboza, J. Altamirano, L. Salinas-Yañez, D. Avecilla-Bonilla (CDMX, Mexico)

    Objective: To describe the clinical course and treatment challenges of early-onset Parkinson’s disease (EOPD) during pregnancy and breastfeeding Background: Parkinson’s disease (PD) is rare in…
  • 2026 International Congress

    Cervical Dystonia: The Objective Evaluation Of Muscle Tone

    M. Falletti (Rome, Italy)

    Objective: In this study, we aimed to assess the biomechanical components underlying the postural alterations characteristic of CD. In addition, we investigated the effects of…
  • 2026 International Congress

    Nutrition and Dietary Assessment as a Wellness Factor in Parkinson’s Disease and Related Disorders

    N. Hellmers, B. Katz, M. Bruno, H. Sarva (New York, USA)

    Objective: To characterize nutrition and food related concerns identified during supportive care visits for individuals with Parkinson’s disease (PD) and related disorders. Background: Individuals with…
  • 2026 International Congress

    Association of Sarcopenia with Fear of Falling and Falls in patients with Parkinson’s disease

    I. Dagklis, D. Kazis, S. Bostantjopoulou (Thessaloniki, Greece)

    Objective: This study aimed to determine whether Sarcopenia is related to the risk of falls and to the Fear of Falling (FOF) in patients with…
  • 2026 International Congress

    Underestimation of Nighttime Sleep Symptoms in Isolated RBD is Associated with Increased Risk of Phenoconversion to Synucleinopathy: A North American Prodromal Synucleinopathy Consortium Study

    J. Ha, D. Bliwise, H. Dela Cruz, C. Xiong, T. Ferman, K. Kantarci, V. Lowe, S. Criswell, E. ST. Louis, D. Huddleston, A. Avidan, Y. Ju, M. Lim, M. Miglis, R. Postuma, A. Videnovic, B. Boeve, M. Howell, L. Trotti (Atlanta, USA)

    Objective: To determine whether mismatch between participant (PT) self-perceived and bed partner (BP)–reported sleep symptoms is associated with risk of phenoconversion to synucleinopathy. Background: Patients…
  • 2026 International Congress

    Two Voices, One Disease: Patient and Care Partner Decision Dynamics on Advanced Therapies for Parkinson’s Disease

    W. Zhang, C. Jimenez Moreno, T. Tervonen, G. Al-Jassar, M. Kirchner, M. Penn, T. Machewitz, C. de Vries, A. Gabriel, C. Gøtzsche, J. Lott, A. Merriam Crespo, A. Mitchell, M. de Leon (Berlin, Germany)

    Objective: To characterize decision dynamics between patients with Parkinson’s disease (PwP) and their care partners (CP) on initiation of advanced therapies. Background: Factors guiding decisions…
  • 2026 International Congress

    Acute administration of methylphenidate modulates functional connectivity during the processing of irrelevant stimuli in Parkinson’s disease patients

    N. Fogelson, L. Li, B. Tan, E. Martinez Lopez, M. Roson Gonzalez, M. Fernandez Delolmo, T. Gurevich, L. Vela Desojo (Fuenlabrada, Spain)

    Objective: Examine the effects of a single dose of methylphenidate (MPD), on event-related functional connectivity (FC), in patients with Parkinson’s disease (PD). Background: Recent studies…
  • 2026 International Congress

    Mild Motor Impairments in Rapid Eye Movement Behavior Disorder: Tremor and Bradykinesia

    JH. Lee, ER. Tobin, EA. Christou, XY. Lou, M. Louis, LH. Le, MF. Presti, MS. Jaffee, DE. Vaillancourt (Gainesville, USA)

    Objective: We investigated patients with RBD to identify mild motor impairments through the objective quantification of sensitive motor control assays. Background: It is established that…
  • 2026 International Congress

    Exploratory Results From a Phase 1 Study of NIO752 in Progressive Supranuclear Palsy Supporting Further Clinical Studies

    M. Brys, M-A. Valentin, S. Menon, N. Pezous, M. Meadowcroft, H. Gunduz-Bruce, C. Serban, L. Kovacic, M-E. Riviere, D. Singh Juneja, A. Graf, L. Vandevrede, G. Höglinger (East Hanover, USA)

    Objective: To report exploratory analyses of biomarker and clinical outcomes from a first-in-human study of NIO752 in progressive supranuclear palsy (PSP) and provide rationale for…
  • « Previous Page
  • 1
  • …
  • 82
  • 83
  • 84
  • 85
  • 86
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley